Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × trastuzumab deruxtecan × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 8 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡